Institutional investors hold a majority ownership of ZTS through the 94.77% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2015, these large investors purchased a net $37.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANTILLON CAPITAL MANAGEMENT LLC Bought 3.9 Million shares of Zoetis Inc